DOM: Difference between revisions
>Dextromethorphan added new od section |
>Dextromethorphan added most important binding affinities |
||
Line 19: | Line 19: | ||
==Pharmacology== | ==Pharmacology== | ||
{{Further|Serotonergic psychedelic}} | {{Further|Serotonergic psychedelic}} | ||
DOM is a selective [[Serotonin#The 5-HT System|5-HT<sub> | DOM is a selective [[agonist|partial agonist]] at the [[Serotonin#The 5-HT System|5-HT<sub>2</sub> receptor]] family. Its psychedelic effects are mediated by its [[agonist]]ic properties at the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors, but less so on the 5-HT<sub>2C</sub> receptor. Due to its selectivity, DOM is often used in scientific research when studying the [[Serotonin#The 5-HT System|5-HT<sub>2</sub> receptor]] subfamily. | ||
{| class="wikitable" | |||
|- | |||
! Site !! Binding Affinity (nM)<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814854/</ref> | |||
|- | |||
| 5-HT<sub>2A</sub> || 507 | |||
|- | |||
| 5-HT<sub>2B</sub> || 11.7 | |||
|- | |||
| 5-HT<sub>2C</sub> || 3'980 | |||
|- | |||
| 5-HT<sub>1D</sub> || 209 | |||
|- | |||
| β<sub>2</sub> || 48.9 | |||
|} | |||
DOM is a [[Chirality|chiral]] molecule, and ''R''-(-)-DOM is the more active [[enantiomer]], functioning as a potent agonist of the serotonin family of receptors (mainly of the 5-HT<sub>2</sub> subtype).<ref>Sanders-Bush, Burris, KD; Knoth, K, (September 1988). "Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis" http://www.ncbi.nlm.nih.gov/pubmed/2843634</ref> | DOM is a [[Chirality|chiral]] molecule, and ''R''-(-)-DOM is the more active [[enantiomer]], functioning as a potent agonist of the serotonin family of receptors (mainly of the 5-HT<sub>2</sub> subtype).<ref>Sanders-Bush, Burris, KD; Knoth, K, (September 1988). "Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis" http://www.ncbi.nlm.nih.gov/pubmed/2843634</ref> |